BRKRP · NASDAQ
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
$419.43 -1.06 (-0.25%)
Company overview
Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) BioSpin, BSI Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID), BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The BSI BioSpin segment includes life science tools based on magnetic resonance technology.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NASDAQ
- Market cap
- $63.9B
- Employees
- 11,396
- Headquarters
- Billerica, MA
- Website
- bruker.com
- CEO
- Frank H. Laukien
- Listed
- September 8, 2025
- P/E
- -1,754.94
- Dividend yield
- 3.67%
Company financials
- Revenue
- $3.5B
- Gross profit
- $1.6B
- Operating income
- $204M
- EBITDA
- $317M
- Net income
- -$11.6M
- EPS
- -$0.24
- Total assets
- $6.1B
- Total debt
- $1.7B
- Gross margin
- 45.56%
- Net margin
- -0.34%
- Earnings yield
- -0.06%
No annual segmentation.
No annual segmentation.
News
| Ticker | Type | Headline | Source | Published |
|---|---|---|---|---|
| BRKRP | Stock news | Bruker Corporation (BRKR) Q1 2026 Earnings Call Transcript | Seeking Alpha |